INTERNATIONAL PATENT: 4TEEN4 PHARMACEUTICALS GMBH FILES APPLICATION FOR "ANTI-DPP3 ANTIBODY DIRECTED TO AND BINDING TO DPP3 FOR THE TREATMENT OF SHOCK IN EXTREME-CRITICALLY ILL PATIENTS"

GENEVA, March 9 -- 4TEEN4 PHARMACEUTICALS GMBH (NeuendorfstraBe 15A16761 Hennigsdorf) filed a patent application (PCT/EP2025/074188) for "ANTI-DPP3 ANTIBODY DIRECTED TO AND BINDING TO DPP3 FOR THE TREATMENT OF SHOCK IN EXTREME-CRITICALLY ILL PATIENTS" on Aug 26, 2025. With publication no. WO/2026/046947, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BERGMANN, Andreas (Am Rosenanger 7813465 Berlin)

Abstract: The present invention relates to an anti-DPP3 antibody or fragment thereof binding to DPP3 for the treatment of s...